Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O)

This is a single-center pilot study of open-label, non-randomized interventional research based on the outpatient management of 30 patients with T1-N0 or T2-N0 cancer in the oral cavity or oropharynx.

Trial Details

NCT ID
NCT03545256
Phase
NA
Sponsor
University Hospital, Montpellier
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity or oropharynx with lymph node search
Locations (sample)
  • Montpellier, Hérault, France|43.61093,3.87635

Key Eligibility Criteria

  • Male or female over 18 years old with no upper age limit
  • Patient (s) affiliated to a social security system, or beneficiary of such a system
  • Patient information and informed consent signed by the patient
  • Patient no longer participating in another trial since legal time

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →